D-1426-2012 Class III Terminated

Recalled by Fougera Pharmaceuticals, Inc. — Hicksville, NY

FDA drug recall D-1426-2012 was initiated by Fougera Pharmaceuticals, Inc. on Jun 7, 2012 and is designated Class III. Reason for recall: Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product. The recall status is terminated (terminated Nov 30, 2015). Affected quantity: 444 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 1, 2012
Initiation Date
Jun 7, 2012
Termination Date
Nov 30, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
444 bottles

Product description

Erythromycin Topical Solution USP, 2%, 60 mL bottle with applicator, Rx only. E. FOUGERA & CO., A division of Fougera Pharmaceuticals, Inc., Melville, New York 11747, NDC 0168-0215-60, UPC 3 0168-0215-60 0.

Reason for recall

Chemical Contamination: This product is being recalled because trace amounts of a plasticizer (Di-Octyl Phthalate) may be present in the product.

Distribution pattern

Nationwide.

Code information

Lot #: 418N, Exp 06/13

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1426-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1426-2012. Report a data issue: hello@regdatalab.com.